Business
The deal expands an earlier agreement with ViaCell, which cancels its initial public offering.
Jan. 1, 2004
Amgen Inc.’
May 17, 2002
Amgen Inc. said Wednesday that fourth-quarter earnings fell 23%, reflecting a $203-million charge arising from unsuccessful drug collaborations.
Jan. 24, 2002
Technology and the Internet
Amgen Inc. announced that Kevin Sharer has been named president and chief operating officer.
Oct. 17, 1992
Biotechnology company Amgen Inc. said Friday that it would buy privately held Avidia Inc. for $290 million in cash and additional milestone payments.
Sept. 30, 2006
Amgen Inc., one of the world’s biggest biotechnology companies, and NPS Pharmaceuticals Inc. said they will develop and market NPS’ thyroid disease drug, Norcalcin, in an agreement valued at $43.5 million.
Dec. 29, 1995
Santa Monica-based Kite Pharma Inc. is teaming up with biotech giant Amgen Inc. to develop cancer treatments, a deal that sent Kite’s stock soaring.
Jan. 5, 2015
Amgen Inc. won a widely watched patent dispute Friday over an anemia drug that brings it $2.4 billion a year in sales.
Oct. 16, 2004
A federal appeals court Monday revived Genentech Inc.’
April 30, 2002
In good news for rival Amgen, the drug maker says the FDA won’t clear Mircera before a safety review this fall.
May 19, 2007